---
title: "LHC Group -> Optum Acquisition"
description: "UnitedHealth's Optum acquired LHC Group, one of the nation's largest home health and hospice providers, for $5.4B to accelerate its payvider model and value-based care strategy."
date: "2023-02-22"
slug: "lhc-group-optum-2023"
published: true
tags: ["payer-integration", "home-health", "payvider", "value-based-care", "2023"]
excerpt: "$5.4B acquisition of home health provider with 527 locations and 435+ hospital partnerships"
readTime: "12 min read"
---

# LHC Group -> Optum (UnitedHealth Group) Acquisition

*Research Completed: 2026-01-03*
*Transaction Status: Closed*

---

## Deal Summary

UnitedHealth Group's Optum subsidiary acquired LHC Group, one of the nation's largest home health and hospice providers, for $5.4 billion ($170 per share) in an all-cash transaction. This was a transformational deal for Optum's value-based care strategy, adding 30,000 employees, 527 home health locations, and over 12 million annual in-home patient interventions across 37 states. The acquisition represented UnitedHealth's aggressive push to capture the shift toward home-based care delivery and accelerate its "payvider" (payer + provider) model.

**Key Metrics:**
| Metric | Value | Confidence | Source |
|--------|-------|------------|--------|
| Deal Value | $5.4B | High | [2023-02-22](https://homehealthcarenews.com/2023/02/5-4-billion-lhc-group-optum-deal-closes/) |
| Price Per Share | $170 | High | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| Target Revenue (2022 guidance) | $2.5B | High | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| Target EBITDA (2022 guidance) | $280M | High | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EBITDA Margin | 11.2% | High | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EV/Revenue | 2.2x | Medium | [calculated: $5.4B / $2.5B] |
| EV/EBITDA | 19.3x | Medium | [calculated: $5.4B / $280M] |
| Employees | 30,000 | High | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| Home Health Locations | 527 | High | [2023-02-22](https://homehealthcarenews.com/2023/02/5-4-billion-lhc-group-optum-deal-closes/) |
| Hospital Partnerships | 435+ | High | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |

---

## Exit Scenario Analysis

**Pattern Identified**: Payer Vertical Integration / Payvider Buildout

This deal is a textbook example of a major payer (UnitedHealth) vertically integrating into care delivery, specifically home-based post-acute care. It directly parallels Humana's acquisition of Kindred at Home and represents the most aggressive move in a payer "arms race" to own home health capabilities.

**Why This Classification**:
UnitedHealth, through Optum, has been systematically building an integrated care delivery system that spans primary care (60,000+ aligned physicians), ambulatory surgery, behavioral health, and now home-based care. LHC Group fills a critical gap in the post-acute continuum, enabling Optum to manage patients from hospital discharge through recovery at home.

**Evidence**:
- UnitedHealth CEO Andrew Witty stated [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/): "It's not just about the clinics; it's now about the home and the community"
- Optum COO Dirk McMahon indicated [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) that "at-home capabilities... [will] generate a significant portion of our value-based care growth"
- The deal directly followed Humana's $5.7B acquisition of Kindred at Home, indicating competitive urgency
- LHC Group had 435+ hospital partnerships, providing discharge referral channels
- LHC quality scores ran "more than one-third higher than industry norms" [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/)

**What's Interesting/Unusual About This Deal**:
1. **Competitive response to Humana**: This acquisition came within months of Humana fully integrating Kindred at Home, showing payers racing to lock up home health scale
2. **FTC scrutiny**: The deal faced multiple information requests from the FTC, including specific inquiry into worker pay practices - unusual for a vertical transaction
3. **Founder commitment**: Co-founders Keith and Ginger Myers personally invested $10M in UNH stock post-close, signaling confidence
4. **Premium valuation**: 19x EBITDA is aggressive for home health, reflecting strategic value beyond standalone financials
5. **Subsequent Amedisys bid**: Just months after closing LHC, UnitedHealth bid $3.3B for Amedisys [2023-06](https://www.healthcaredive.com/news/unitedhealth-optum-amedisys-acquisition-option-care/653870/), showing continued appetite

**Confidence in Classification**: High - This is clearly a payer vertical integration play with explicit strategic rationale documented in public statements.

---

## The Deal

### Transaction Structure

**Deal Type**: All-cash acquisition
**Price**: $170 per share
**Total Value**: ~$5.4 billion (including assumption of debt)
**Acquirer**: UnitedHealth Group through Optum Health subsidiary
**Structure**: LHC Group became a wholly-owned subsidiary of Optum; stock delisted from NASDAQ

### Valuation Analysis

| Metric | Value | Calculation/Source |
|--------|-------|-------------------|
| Enterprise Value | $5.4B | [2023-02-22](https://homehealthcarenews.com/2023/02/5-4-billion-lhc-group-optum-deal-closes/) |
| Equity Value | ~$5.4B | $170/share transaction |
| Revenue (2021 actual) | $2.2B | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| Revenue (2022 guidance) | $2.5B | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EBITDA (2021 actual) | $216M | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EBITDA (2022 guidance) | $280M | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EV/Revenue (2022E) | 2.2x | Calculated |
| EV/EBITDA (2022E) | 19.3x | Calculated |
| EBITDA Margin (2021) | ~10% | Calculated |
| EBITDA Margin (2022E) | 11.2% | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |

**Multiple Context**:
- The 2.2x revenue multiple is reasonable for home health services
- The 19x+ EBITDA multiple reflects strategic premium for:
  - Scale (one of top 3 home health providers nationally)
  - Quality (above-industry-norm scores)
  - Hospital partnerships (435+ referral relationships)
  - Geographic coverage (37 states + DC)
  - Value-based care readiness

### Deal Timeline

| Date | Event |
|------|-------|
| 1994 | LHC Group founded by Keith and Ginger Myers as single home health agency |
| 2005-06-10 | LHC Group IPO on NASDAQ |
| 2021-08 | Humana completes Kindred at Home acquisition for $5.7B (competitive pressure) |
| 2022-03-29 | Optum announces agreement to acquire LHC Group [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| 2022-H1 | FTC requests additional information (first request) |
| 2022-H2 | FTC requests additional information (second request, focused on worker pay) |
| 2023-02-22 | Deal closes; LHC Group delisted from NASDAQ [2023-02-22](https://homehealthcarenews.com/2023/02/5-4-billion-lhc-group-optum-deal-closes/) |
| 2023-06 | UnitedHealth announces $3.3B bid for Amedisys (continued home health appetite) |

### Regulatory & Structural Considerations

The FTC scrutinized this deal but ultimately did not challenge it:
- **First information request**: Standard additional review
- **Second information request**: Focused specifically on labor practices and worker pay in home health sector [2023-02-22](https://homehealthcarenews.com/2023/02/5-4-billion-lhc-group-optum-deal-closes/)
- **Vertical harm theory**: Reports emerged of potential review under vertical harm theory, but no formal challenge materialized
- **No divestitures required**: Deal closed without structural remedies

---

## Target Company

### What They Do

LHC Group was a national provider of in-home healthcare services, primarily home health, hospice, and home- and community-based services. The company had a strong focus on quality and patient outcomes, with scores consistently above industry norms.

**Service Lines**:
- **Home Health**: Skilled nursing, physical/occupational/speech therapy in patient homes
- **Hospice**: End-of-life care and support
- **Home and Community-Based Services (HCBS)**: Personal care, companion care
- **Facility-Based Care**: Limited institutional presence

**Operating Model**: LHC operated through a mix of wholly-owned locations and hospital joint ventures. The 435+ hospital partnerships were critical for patient referrals at discharge - directly relevant to care transitions.

### Scale & Financials

| Metric | Value | Source |
|--------|-------|--------|
| Revenue (2021) | $2.2B | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| Revenue (2022 guidance) | $2.5B | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| Revenue Growth | ~14% YoY | Calculated |
| EBITDA (2021) | $216M | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EBITDA (2022 guidance) | $280M | [2022-11-03](https://hospitalogy.com/articles/2022-11-03/6-biggest-health-tech-services-deals-2022/) |
| EBITDA Margin | 10-11% | Calculated |
| Employees | 30,000 | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| Home Health Locations | 527 | [2023-02-22](https://homehealthcarenews.com/2023/02/5-4-billion-lhc-group-optum-deal-closes/) |
| Total Locations | 964 | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| States Covered | 37 + DC | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| Population Reach (65+) | 60% of U.S. | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| Hospital Partnerships | 435+ | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |
| Annual In-Home Interventions | 12M+ | [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/) |

### Company History

LHC Group's journey from startup to $5.4B exit:
- **1994**: Founded by Keith and Ginger Myers as single-location home health agency in Louisiana
- **2001**: Became subsidiary of The Healthcare Group
- **2005**: Merged with The Healthcare Group; IPO on NASDAQ (June 10)
- **2005-2022**: Expanded through acquisitions and organic growth to become top-3 national home health provider
- **2023**: Became wholly-owned subsidiary of Optum

### The "Crown Jewel"

LHC Group's core value resided in:
1. **Hospital partnership network**: 435+ hospital relationships providing direct referral channels at discharge
2. **Quality scores**: Consistently 1/3 higher than industry norms
3. **Geographic scale**: 60% coverage of 65+ population across 37 states
4. **Value-based care readiness**: Experience with risk-based arrangements and quality metrics
5. **Workforce**: 30,000 trained home health clinicians (scarce resource)

### Leadership at Acquisition

**Keith G. Myers** - Chairman & CEO
- Co-founded LHC Group with wife Ginger in 1994
- Built company from single agency to national scale over 28 years
- Personally invested $10M in UNH stock post-close
- Leadership team continued within Optum Health

---

## Acquirer Context

### Who They Are

UnitedHealth Group is the largest healthcare company in the United States by revenue, operating through two main divisions:

**UnitedHealthcare** (Insurance):
- Largest health insurer in U.S.
- ~50M members across commercial, Medicare, Medicaid

**Optum** (Health Services):
- **Optum Health**: Care delivery (60,000+ aligned physicians, clinics, ASCs)
- **Optum Rx**: Pharmacy benefit management
- **OptumInsight**: Data, analytics, technology services

**Scale (at acquisition)**:
- ~$320B annual revenue (2022)
- 400,000+ employees globally
- Operations across 50 states

### Why They Bought This

**Stated Rationale** [2022-03-29](https://lhcgroup.com/newsroom/optum-and-lhc-group-to-combine-advancing-abilities-to-extend-value-based-care-into-patients-homes/):
> "LHC Group's sophisticated care coordination capabilities and its warm, human touch is so important for home care, and will greatly enhance the reach of Optum's value-based capabilities along the full continuum of care, including primary care, home and community care, virtual care, behavioral health and ambulatory surgery." - Dr. Wyatt Decker, CEO, Optum Health

**Strategic Logic**:
1. **Complete the care continuum**: Add post-acute/home care to Optum Health's primary care and specialty capabilities
2. **Value-based care acceleration**: Home health is critical for managing costs and outcomes under risk-based contracts
3. **Competitive response**: Match Humana's Kindred at Home acquisition
4. **Hospital referral channel**: 435+ hospital partnerships provide patient acquisition infrastructure
5. **Medicare Advantage synergy**: Home health increasingly critical for MA plan performance

### Prior M&A Pattern (Optum Home Health/Care Focus)

| Year | Target | Value | Focus |
|------|--------|-------|-------|
| 2020 | naviHealth | $2.5B | Post-acute care navigation |
| 2021 | Landmark Health | Undisclosed | In-home medical group for complex patients |
| 2023 | LHC Group | $5.4B | Home health and hospice |
| 2023 | Amedisys (bid) | $3.3B | Home health and hospice (pending regulatory) |

Optum has been systematically building a home-based care empire, spending $10B+ on home-related acquisitions.

---

## Strategic Analysis

### Stated Rationale vs. Probable Reality

**Stated**: Extend value-based care capabilities, improve patient outcomes, reduce fragmentation

**Probable Reality**:
1. **Competitive urgency**: Humana's Kindred at Home acquisition created FOMO; UnitedHealth couldn't let a major competitor dominate home health
2. **Cost control in MA**: With 50M+ members, even marginal home health cost savings are worth billions
3. **Lock up referral channels**: 435 hospital partnerships represent significant patient flow infrastructure
4. **Labor market advantage**: 30,000 home health workers are increasingly scarce; ownership provides preferential access
5. **Medicare Advantage imperatives**: CMS Star ratings increasingly emphasize care transitions and post-acute outcomes

### Value Capture Mechanism

Optum's thesis for value creation:
1. **Medical cost reduction**: Steer UnitedHealthcare members to owned home health (lower costs, better coordination)
2. **Risk-based contracting**: Better manage total cost of care for MA and ACO populations
3. **Quality improvement**: LHC's above-average quality scores enhance MA Star ratings
4. **Referral integration**: Connect 60,000+ Optum physicians with LHC for seamless discharge planning
5. **Data and analytics**: Combine home health data with Optum's clinical and claims data for predictive analytics

### Competitive Implications

This deal fundamentally altered the competitive landscape:
- **Humana vs. UnitedHealth**: The two largest MA insurers now own the two largest home health providers
- **Fewer independent options**: Public home health companies reduced to Amedisys, Enhabit, Aveanna, Pennant, Addus
- **Hospital bargaining power shift**: Health systems may face vertically integrated payer-providers as partners
- **Provider consolidation pressure**: Smaller home health agencies face competitive disadvantage

### Post-Deal Integration

LHC Group is being integrated into Optum Health's care delivery network:
- Maintaining LHC Group brand and leadership
- Connecting to Optum's primary care network (60,000+ physicians)
- Integrating data and analytics platforms
- Enabling care coordination across Optum's full continuum

---

## Relevance to Dimer Health

### Similarities

| Dimension | LHC Group | Dimer Health |
|-----------|-----------|--------------|
| Care Transitions Focus | Hospital-to-home care delivery | Post-discharge transitional care |
| Quality Emphasis | 1/3 above industry norms | 67% readmission reduction |
| Hospital Relationships | 435+ partnerships | Health system partnerships (Atlantic, Bergen, RWJBarnabas) |
| Value-Based Alignment | Experience with risk-based contracts | Aligned with CMS readmission penalties/VBC |
| Clinical Model | In-home skilled nursing/therapy | Virtual + AI-augmented physician care |

### Key Differences

| Dimension | LHC Group | Dimer Health |
|-----------|-----------|--------------|
| Scale | $2.5B revenue, 30,000 employees | ~$7.8M revenue, ~42 employees |
| Delivery Model | Physical in-home visits | Virtual-first (telehealth + AI) |
| Service Scope | Full home health (nursing, therapy, hospice) | Transitional care specialization |
| Geographic Coverage | 37 states + DC | 5 states (NY, NJ, PA, FL, TX) |
| Business Model | Fee-for-service + some VBC | B2B to health systems/payers |

### Implications for Dimer

1. **Payer buyer interest**: UnitedHealth/Optum paid 2.2x revenue for home health - validates payer appetite for care transition capabilities
2. **Strategic premium**: 19x EBITDA reflects strategic value beyond standalone financials for the right buyer
3. **Quality matters**: LHC's above-average quality scores were explicitly cited as value driver - Dimer's 67% readmission reduction is similarly differentiated
4. **Hospital partnerships**: LHC's 435 hospital relationships were a core asset - Dimer's health system partnerships (Atlantic, RWJBarnabas) could be similarly valuable
5. **Virtual vs. physical**: Dimer's virtual-first model may command different multiples than physical home health, but the care transitions mission is aligned
6. **Complementary positioning**: Dimer could complement an LHC-style acquirer by adding virtual transitional care to physical home health capabilities

---

## Comparable Transactions (Post-Acute/Home Health)

| Target | Acquirer | Year | Value | EV/Revenue | Notes |
|--------|----------|------|-------|------------|-------|
| LHC Group | Optum | 2023 | $5.4B | 2.2x | 19x EBITDA; 30K employees |
| Kindred at Home | Humana | 2021 | $8.1B EV | ~2.7x | $3B revenue; 43K employees |
| naviHealth | Optum | 2020 | $2.5B | ~10x | Post-acute navigation platform |
| Amedisys (bid) | UnitedHealth | 2023 | $3.3B | ~2x | Pending regulatory review |
| CarePort Health | WellSky | 2022 | $1.35B | N/A | Care coordination software |
| Signify Health | CVS | 2022 | $8B | ~14x | In-home evaluations + VBC |

---

## Research Notes

### Key Sources
- LHC Group press releases and SEC filings
- UnitedHealth Group investor presentations
- Home Health Care News coverage
- Hospitalogy deal analysis
- SEC Form 8-K filings

### Data Gaps & Limitations
- Specific synergy targets not disclosed
- Integration progress and performance not publicly tracked
- LHC segment financials no longer reported separately post-acquisition
- Worker pay/labor practices scrutinized by FTC but details not public

### Open Questions
- How is LHC integration performing within Optum Health?
- What happened with the Amedisys acquisition attempt?
- Has the FTC's labor-focused scrutiny led to policy changes?
- How much patient steering occurs from UnitedHealthcare plans to LHC?

---

## Tags

`payer-vertical-integration` `home-health` `hospice` `value-based-care` `optum` `unitedhealth` `2023` `2x-revenue` `19x-ebitda` `care-transitions`

---

*Research completed: 2026-01-03*
